Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

259
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
259
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

109
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
109
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

103
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
103
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

91
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
91
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

82
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
82
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

134
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
134

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing Robotic Surgical Competence in Colorectal Surgery: MGEARS Scores Are Independent of Overall Case Volume.

Journal of laparoendoscopic & advanced surgical techniques. Part A·2026
Same author

Surgical Management of Colorectal Cancer Peritoneal Metastases: Current Indications, Controversies, and Future Directions.

Digestive surgery·2026
Same author

Preoperative risk assessment for surgical operations using artificial intelligence: Potential benefits, hurdles, and future directions.

Surgery·2026
Same author

Evaluation of the National Accreditation Program for Rectal Cancer and Association with Oncologic Outcomes After Proctectomy.

Journal of the American College of Surgeons·2026
Same author

Osteosarcopenia May Be Associated with Complications after Colectomy for Diverticulitis.

The Israel Medical Association journal : IMAJ·2026
Same author

ASO Visual Abstract: A Clinical Primer for Defining Time Zero in Rectal Cancer Studies of Nonoperative Management: Implications for Survival and Local Regrowth.

Annals of surgical oncology·2026

Related Experiment Video

Updated: May 16, 2025

Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing
07:38

Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing

Published on: September 13, 2016

8.3K

Multi-disciplinary teams for Crohn's disease: Who should be presented?

Meagan Derbyshire1, Yaniv Zager1, Katherine Carson2

  • 1Department of Colon & Rectum Surgery, AdventHealth, Orlando, FL, USA; Surgical Health Outcomes Consortium (SHOC), Advent Health Digestive Institute, Orlando, FL, USA.

The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland
|April 2, 2025
PubMed
Summary

Multi-disciplinary team (MDT) conferences for Crohn's Disease (CD) patients tend to present younger individuals with lower BMI, often leading to surgical intervention. Further research is needed to define optimal patient selection for these crucial discussions.

Keywords:
Crohn's disease (CD)Inflammatory bowel disease (IBD)Multi-disciplinary team (MDT)

More Related Videos

A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease
05:08

A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease

Published on: March 1, 2022

3.6K
Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.0K

Related Experiment Videos

Last Updated: May 16, 2025

Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing
07:38

Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing

Published on: September 13, 2016

8.3K
A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease
05:08

A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease

Published on: March 1, 2022

3.6K
Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.0K

Area of Science:

  • Gastroenterology
  • Colorectal Surgery
  • Inflammatory Bowel Disease Research

Background:

  • Multi-disciplinary team (MDT) conferences are standard in managing benign and malignant colorectal diseases.
  • Evidence supporting the benefit and patient selection for MDT in inflammatory bowel disease (IBD), particularly Crohn's Disease (CD), is limited.
  • Advancements in IBD management necessitate clear clinical decision-making strategies.

Purpose of the Study:

  • To identify patient demographics and characteristics currently presented at MDT conferences for CD.
  • To assess the adherence to MDT recommendations in CD patient management.
  • To compare outcomes between CD patients discussed in MDT versus those not.

Main Methods:

  • A retrospective, observational study was conducted over twelve months within a hospital system.
  • Data was collected from prospective MDT databases and retrospective chart reviews.
  • Statistical analysis, including chi-square and student t-tests, compared patients presented at MDT with those not.

Main Results:

  • 52 out of 766 CD patients were reviewed at MDT conferences.
  • Patients presented at MDT were younger (43.4 vs. 44.9 years) and had lower BMIs (23.6 vs. 26.1) compared to non-MDT patients (p < 0.05).
  • Surgical intervention was significantly more frequent in the MDT group (46.2% vs. 23.2%, p < 0.05).

Conclusions:

  • MDT conferences can guide treatment decisions for IBD and CD.
  • Current trends suggest a preference for presenting younger, lower BMI CD patients for surgical consideration.
  • Further prospective studies are required to establish definitive criteria for MDT presentation in CD management.